ADHERE: randomized controlled trial comparing renal function inde novokidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus-Reference-Cited by-同舟云学术

ADHERE: randomized controlled trial comparing renal function inde novokidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus

Published:2016-11-28 Issue:1 Volume:30 Page:83-95
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Rummo Oleg O.¹,Carmellini Mario²,Rostaing Lionel³,Oberbauer Rainer⁴,Christiaans Maarten H. L.⁵,Mousson Christiane⁶,Langer Robert M.⁷,Citterio Franco⁸,Charpentier Bernard⁹,Brown Malcolm¹⁰,Kazeem Gbenga¹¹,Lehner Frank¹²,

Affiliation:

1. Republican Scientific and Practical Center (RSPC) for Organ and Tissue Transplantation; Minsk Belarus

2. Department of Medical, Surgical and Neuroscience; Policlinico Santa Maria alle Scotte; University of Siena; Siena Italy

3. Department of Nephrology, Dialysis and Organ Transplantation; Toulouse University Hospital; INSERM U563, IFR-BMT, CHU Purpan; Toulouse France

4. Department of Internal Medicine III, Nephrology and Dialysis; Medical University of Vienna; Vienna Austria

5. Department of Internal Medicine/Division of Nephrology; Maastricht University Medical Center; Maastricht The Netherlands

6. Department of Nephrology-Transplantation; University Hospital; Dijon France

7. Department of Transplantation and Surgery; Semmelweis University; Budapest Hungary

8. Department of Surgery, Renal Transplantation; Catholic University; Rome Italy

9. Department of Nephrology, Dialysis and Transplantation; University Hospital of Bicêtre; Le Kremlin Bicetre France

10. Medical Affairs - Global; Astellas Pharma; Northbrook IL USA

11. Astellas Pharma Europe Ltd; Chertsey UK

12. General, Visceral and Transplantation Surgery; Hannover Medical School; Hannover Germany

Funder

Astellas Pharma

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12878/fullpdf

Reference29 articles.

1. Novel immunosuppressive agents in kidney transplantation;Hardinger;World J Transplant,2013

2. Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study;Mayer;Transplant Proc,2002

3. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes;Gondos;Transplantation,2013

4. Chronic renal allograft dysfunction;Chapman;J Am Soc Nephrol,2005

5. Identifying specific causes of kidney allograft loss;El-Zoghby;Am J Transplant,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07

2. Safety and Efficacy of Mycophenolate Mofetil Associated With Tacrolimus for Kidney-pancreas and Kidney Transplantation: A Systematic Review and Meta-Analysis of Randomized Studies;Transplantation Proceedings;2024-06

3. Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis;Journal of Clinical Medicine;2022-07-20

4. Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation;Transplant International;2022-05-20

5. New Immunosuppressive Strategies to Achieve Better Compliance and Results;Experimental and Clinical Transplantation;2022-05